Ann: MDR - Canaccord Growth Conference, page-4

PME showing the market the US is where the big dollars are found.

MDRs 5 year plan looks to align with the metrics that is keeping PMEs share price buoyant.

Bringing in more revenue, building margins and cost management to increase profits.

PME revenues aren’t that much higher than MDR. Margin, NPAT and cash is where the chasm exists and arguably where the market decides valuation.

We’re half way through the first quarter. If September brings in $30M revenue, FY25 would be off to a great start. With $122M for FY24 I suspect Management would be looking at ~20% increase for the year, so would like to crack $150M.